Insight Molecular Diagnostics Stock Buy Hold or Sell Recommendation
| IMDX Stock | 6.37 0.55 9.45% |
Given the investment horizon of 90 days and your typical level of risk aversion, our recommendation regarding Insight Molecular Diagnostics is 'Strong Hold'. A buy or sell recommendation is an automated directive regarding whether to purchase or sell Insight Molecular Diagnostics given historical horizon and risk tolerance. When we issue a 'buy' or 'sell' recommendation for Insight Molecular Diagnostics, the advice is generated through an automated system that utilizes algorithms and statistical models.Check out Insight Molecular Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. In addition, we conduct extensive research on individual companies such as Insight and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Insight Molecular Diagnostics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in small area income & poverty estimates.
Execute Insight Molecular Buy or Sell Advice
The Insight recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Insight Molecular Diagnostics. Macroaxis does not own or have any residual interests in Insight Molecular Diagnostics or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Insight Molecular's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Hold
Market Performance | Good | Details | |
Volatility | Relatively risky | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Fairly Valued | Details | |
Odds Of Distress | High | Details | |
Economic Sensitivity | Hyperactively responds to market trends | Details | |
Investor Sentiment | Interested | Details | |
Analyst Consensus | Not Available | Details | |
Financial Strenth (F Score) | Healthy | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Insight Molecular Trading Alerts and Improvement Suggestions
| Insight Molecular is way too risky over 90 days horizon | |
| Insight Molecular appears to be risky and price may revert if volatility continues | |
| Insight Molecular has high likelihood to experience some financial distress in the next 2 years | |
| Insight Molecular Diagnostics was previously known as OCX Old and was traded on NASDAQ Exchange under the symbol OCX. | |
| The company reported the previous year's revenue of 1.88 M. Net Loss for the year was (60.66 M) with profit before overhead, payroll, taxes, and interest of 2.09 M. | |
| Insight Molecular generates negative cash flow from operations | |
| About 56.0% of the company shares are owned by institutional investors | |
| Latest headline from simplywall.st: Hedge funds investors control 50 percent of Insight Molecular Diagnostics Inc. and were rewarded last week after stock increased 11 |
Insight Molecular Returns Distribution Density
The distribution of Insight Molecular's historical returns is an attempt to chart the uncertainty of Insight Molecular's future price movements. The chart of the probability distribution of Insight Molecular daily returns describes the distribution of returns around its average expected value. We use Insight Molecular Diagnostics price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Insight Molecular returns is essential to provide solid investment advice for Insight Molecular.
| Mean Return | 1.15 | Value At Risk | -6.19 | Potential Upside | 12.20 | Standard Deviation | 5.51 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Insight Molecular historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Insight Molecular Cash Flow Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Change In Cash | (14.9M) | 28.5M | (14.1M) | (12.1M) | (796K) | (756.2K) | |
| Free Cash Flow | (27.2M) | (38.2M) | (49.9M) | (23.6M) | (21.2M) | (22.3M) | |
| Depreciation | 394K | 4.2M | 5.2M | 1.7M | 1.6M | 1.4M | |
| Other Non Cash Items | (2.2M) | 26.2M | 14.0M | 174K | 37.8M | 39.7M | |
| Capital Expenditures | 1.2M | 2.2M | 4.3M | 281K | 516K | 943.3K | |
| Net Income | (29.9M) | (64.1M) | (72.9M) | (27.8M) | (60.7M) | (57.6M) | |
| End Period Cash Flow | 8.8M | 37.3M | 23.2M | 11.1M | 10.3M | 13.6M |
Insight Molecular Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Insight Molecular or Health Care Equipment & Supplies sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Insight Molecular's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Insight stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.95 | |
β | Beta against Dow Jones | 2.76 | |
σ | Overall volatility | 5.62 | |
Ir | Information ratio | 0.19 |
Insight Molecular Volatility Alert
Insight Molecular Diagnostics shows above-average downside volatility for the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Insight Molecular's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Insight Molecular's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Insight Molecular Fundamentals Vs Peers
Comparing Insight Molecular's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Insight Molecular's direct or indirect competition across all of the common fundamentals between Insight Molecular and the related equities. This way, we can detect undervalued stocks with similar characteristics as Insight Molecular or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Insight Molecular's fundamental indicators could also be used in its relative valuation, which is a method of valuing Insight Molecular by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Insight Molecular to competition |
| Fundamentals | Insight Molecular | Peer Average |
| Return On Equity | -4.29 | -0.31 |
| Return On Asset | -0.22 | -0.14 |
| Operating Margin | (2.73) % | (5.51) % |
| Current Valuation | 54.24 M | 16.62 B |
| Shares Outstanding | 28.6 M | 571.82 M |
| Shares Owned By Insiders | 22.03 % | 10.09 % |
| Shares Owned By Institutions | 56.30 % | 39.21 % |
| Number Of Shares Shorted | 146.31 K | 4.71 M |
| Price To Book | 8.00 X | 9.51 X |
| Price To Sales | 22.55 X | 11.42 X |
| Revenue | 1.88 M | 9.43 B |
| Gross Profit | 2.09 M | 27.38 B |
| EBITDA | (59.02 M) | 3.9 B |
| Net Income | (60.66 M) | 570.98 M |
| Total Debt | 3.66 M | 5.32 B |
| Book Value Per Share | 0.36 X | 1.93 K |
| Cash Flow From Operations | (20.71 M) | 971.22 M |
| Short Ratio | 6.44 X | 4.00 X |
| Earnings Per Share | (3.79) X | 3.12 X |
| Target Price | 5.42 | |
| Number Of Employees | 46 | 18.84 K |
| Beta | 0.99 | -0.15 |
| Market Capitalization | 86.66 M | 19.03 B |
| Total Asset | 35.08 M | 29.47 B |
| Retained Earnings | (350.54 M) | 9.33 B |
| Working Capital | 4.48 M | 1.48 B |
| Net Asset | 35.08 M |
Note: Acquisition by Riggs Josh of 800000 shares of Insight Molecular at 0.2132 subject to Rule 16b-3 [view details]
Insight Molecular Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Insight . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 11609.54 | |||
| Daily Balance Of Power | 0.5238 | |||
| Rate Of Daily Change | 1.09 | |||
| Day Median Price | 5.97 | |||
| Day Typical Price | 6.1 | |||
| Price Action Indicator | 0.68 | |||
| Period Momentum Indicator | 0.55 |
About Insight Molecular Buy or Sell Advice
When is the right time to buy or sell Insight Molecular Diagnostics? Buying financial instruments such as Insight Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Insight Molecular in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Iron Thematic Idea Now
Iron
Companies involved in production of steel and iron. The Iron theme has 39 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Iron Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Insight Stock Analysis
When running Insight Molecular's price analysis, check to measure Insight Molecular's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Insight Molecular is operating at the current time. Most of Insight Molecular's value examination focuses on studying past and present price action to predict the probability of Insight Molecular's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Insight Molecular's price. Additionally, you may evaluate how the addition of Insight Molecular to your portfolios can decrease your overall portfolio volatility.